Dr. Zhang’s Isoflavones Research Receives Widespread Media Attention
Since its publication in early November, Dr. Jianjun Zhang's study on dietary isoflavones has received widespread media attention. In addition to being featured in Medical News Today, Dr. Zhang’s study has been featured in Wiley’s Research Headlines, UK Daily Express Online, Men’s Health, NewsMaxHealth, and NUTRA Ingredients. Dr. Zhang believes the study is making such an impact because it is the first to report that dietary intake of some isoflavones is associated with an elevated risk of advanced prostate cancer, but not non-advanced disease. Dr. Zhang and colleagues analyzed the data of 27,004 men who were part of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. While further studies are necessary, their findings suggest that including soy and other foods rich in isoflavones in the diet may affect men's risk of prostate cancer.